Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 5Pain 3Cachexia 3Breast Neoplasms 3Trigger Finger Disorder 2Prostatic Neoplasms 2Lymphoma, Follicular 2Lung Neoplasms 2Inflammation 2Ganglion Cysts 2De Quervain Disease 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Patient Satisfaction 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Mucositis 1Menorrhagia 1

Interventions

pembrolizumab 1Tomography, X-Ray Computed 1Radiotherapy 1Radionuclide Imaging 1Positron-Emission Tomography 1Oncolytic Virotherapy 1Ibuprofen 1Hydroxyurea 1Fluorouracil 1Electrocardiography 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nose Neoplasms × Ibuprofen × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡